SLC30A4: A Potential Drug Target and Biomarker for Diseases (G7782)

Target Name: SLC30A4

NCBI ID: G7782

SLC30A4

SLC30A4: A Potential Drug Target and Biomarker for Diseases

SLC30A4 is a member of the Solute Carrier Family 30 (SLC30) and is located on chromosome 11p36. It is a transmembrane protein that functions as a carrier for various small molecules, including drugs, toxins, and other substances. SLC30A4 has been identified as a potential drug target and may also be used as a biomarker for various diseases.

SLC30A4 is a member of the SLC30 family, which is known for its ability to transport a wide variety of molecules across cell membranes. This family of proteins is characterized by the presence of a transmembrane region, a cytoplasmic region, and an N-terminal region that is involved in protein-protein interactions. SLC30A4 is similar to other members of the SLC30 family in terms of its structure and function, but it has a unique transcript variant, which is identified by the number of exons at each gene.

SLC30A4 is a transmembrane protein that is involved in the transport of various small molecules across cell membranes. It has been shown to be involved in the transport of a wide range of molecules, including drugs, toxins, and other substances. SLC30A4 is also involved in the regulation of various cellular processes, including cell signaling, DNA replication, and metabolism.

One of the unique features of SLC30A4 is its potential as a drug target. SLC30A4 has been shown to be involved in the regulation of various cellular processes, including cell signaling, DNA replication, and metabolism. This makes it a potential target for a variety of drugs that are designed to modulate these processes. Additionally, SLC30A4 is located on chromosome 11p36, which makes it a potential candidate for targeting diseases that are associated with disruptions in this region of the genome.

In addition to its potential as a drug target, SLC30A4 may also be used as a biomarker for various diseases. As mentioned above, SLC30A4 is located on chromosome 11p36, which makes it a potential candidate for targeting diseases that are associated with disruptions in this region of the genome. Additionally, SLC30A4 has been shown to be involved in the regulation of various cellular processes, which could be used as a biomarker for various diseases. For example, SLC30A4 may be used as a biomarker for cancer, as it has been shown to be involved in the regulation of cell signaling processes that are important for cancer growth.

In conclusion, SLC30A4 is a member of the Solute Carrier Family 30 and is located on chromosome 11p36. It is a transmembrane protein that functions as a carrier for various small molecules, including drugs, toxins, and other substances. SLC30A4 has been identified as a potential drug target and may also be used as a biomarker for various diseases due to its unique structure and function. Further research is needed to fully understand the role of SLC30A4 in cellular processes and its potential as a drug and biomarker.

Protein Name: Solute Carrier Family 30 Member 4

Functions: Probable proton-coupled zinc ion antiporter mediating zinc import from cytoplasm potentially into the endocytic compartment (PubMed:19521526). Controls zinc deposition in milk (By similarity)

The "SLC30A4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC30A4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets